GleamWall
中文EN

NXGL NEXGEL, INC.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1468929 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY5.5%
TTM net income YoY-130.7%
TTM EPS YoY-45.3%
Revenue 3-yr CAGR51.6%
Net income 3-yr CAGR—

Margins

Gross margin33.4%
Operating margin-58.6%
Net margin-54.0%
FCF margin—
EBITDA margin-40.4%

Returns

ROE-142.7%
ROA-37.4%
ROIC (approx.)-153.8%
Asset turnover0.69x

Leverage & solvency

Liabilities / assets80.5%
Debt / equity0.00x
Current ratio0.46x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.53x
Accruals ratio-17.4%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$3.18M$3.69M$2.65M$2.80M$2.93M$2.88M$2.81M$3.04M
Cost of revenue$2.05M$2.58M$1.59M$1.98M$1.69M$1.63M$1.62M$2.26M
Gross profit$1.12M$1.11M$1.06M$819,000$1.24M$1.26M$1.19M$779,000
R&D expense$0$20,000—-$6,000$7,000$0$1,000$0
SG&A expense$3.66M$3.59M$2.02M$2.04M$1.96M$1.89M$1.96M$1.62M
Operating income-$2.54M-$2.50M-$958,000-$1.21M-$725,000-$636,000-$777,000-$841,000
Interest expense———————$14,000
Pretax income-$1.09M-$3.61M-$871,000-$928,000-$647,000-$640,000-$678,000-$824,000
Net income-$1.11M-$3.63M-$927,000-$970,000-$653,000-$665,000-$712,000-$850,000
EBITDA-$1.33M-$1.68M-$859,000-$1.10M-$612,000-$525,000-$663,000-$733,000
EPS (basic)-2.28-0.40-0.11—-1.64-0.09-0.09—
EPS (diluted)-2.28-0.40-0.11—-1.64-0.09-0.09—
Weighted avg. shares (diluted)487,3579.01M8.20M—398,5657.65M7.65M—
Balance sheet
Cash & equivalents$658,000$1.71M$2.12M$317,000$1.86M$725,000$1.19M$1.81M
Receivables$804,000$1.08M$662,000$673,000$839,000$753,000$926,000$933,000
Inventory$2.75M$2.30M$2.26M$2.11M$2.02M$1.82M$1.85M$1.75M
Current assets$4.94M$6.17M$5.64M$4.34M$5.60M$4.16M$4.74M$5.11M
PP&E, net$1.88M$1.91M$1.89M$1.96M$2.00M$2.07M$2.13M$2.21M
Goodwill$1.13M$1.13M$1.13M$1.13M$1.13M$1.13M$1.13M$1.13M
Intangibles$12.34M$13.49M$655,000$681,000$712,000$744,000$681,000$807,000
Total assets$23.90M$26.45M$11.60M$10.46M$11.62M$9.71M$10.44M$10.98M
Current liabilities$10.63M$14.44M$3.31M$2.96M$3.31M$2.40M$2.52M$2.47M
Long-term debt——$563,000$588,000$614,000$638,000$662,000$685,000
Total debt——$563,000$588,000$614,000$638,000$662,000$685,000
Total liabilities$19.23M$20.98M$7.12M$5.57M$6.04M$4.66M$4.87M$4.90M
Shareholders' equity$4.13M$4.95M$3.99M$4.46M$5.19M$4.67M$5.21M$5.75M
Net debt——-$1.56M$271,000-$1.24M-$87,000-$530,000-$1.12M
Shares outstanding487,3839.70M8.48M407,1578.14M7.65M7.65M7.64M
Cash flow statement
Operating cash flow-$1.13M-$2.20M-$504,000$281,000-$785,000-$407,000-$400,000-$859,000
Capital expenditure——$9,000$40,000$8,000——$69,000
Free cash flow——-$513,000$241,000-$793,000——-$928,000
Investing cash flow-$33,000-$6.58M-$9,000-$40,000-$8,000——-$63,000
Financing cash flow$116,000$8.36M$1.58M-$1.04M$1.93M-$40,000-$215,000$1.67M
Depreciation & amortization$1.21M$827,000$99,000$112,000$113,000$111,000$114,000$108,000
Stock-based compensation$15,000$119,000$143,000$156,000$205,000$127,000$166,000$96,000

Free plan shows the latest 8 periods; Pro shows all 35 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.